| Primary |
| Pain |
30.0% |
| Product Used For Unknown Indication |
16.6% |
| Drug Use For Unknown Indication |
8.8% |
| Analgesic Therapy |
6.0% |
| Procedural Pain |
5.5% |
| Anaesthesia |
3.2% |
| General Anaesthesia |
3.2% |
| Headache |
3.2% |
| Renal Colic |
3.2% |
| Cardiac Failure |
2.8% |
| Arthralgia |
2.3% |
| Arthritis |
2.3% |
| Glaucoma |
2.3% |
| Abdominal Pain |
1.8% |
| Hypertension |
1.8% |
| Back Pain |
1.4% |
| Conjunctivitis |
1.4% |
| Muscle Spasms |
1.4% |
| Pain In Extremity |
1.4% |
| Trabeculoplasty |
1.4% |
|
| Renal Failure Acute |
11.4% |
| Urticaria |
9.1% |
| Drug Hypersensitivity |
6.8% |
| Vomiting |
6.8% |
| Anaphylactic Reaction |
5.7% |
| Medication Error |
5.7% |
| Tremor |
5.7% |
| Pulmonary Haemorrhage |
4.5% |
| Renal Tubular Necrosis |
4.5% |
| Tachycardia |
4.5% |
| Throat Tightness |
4.5% |
| Angioedema |
3.4% |
| Convulsion |
3.4% |
| Disseminated Intravascular Coagulation |
3.4% |
| Hypersensitivity |
3.4% |
| Necrotising Fasciitis |
3.4% |
| Pain |
3.4% |
| Pulmonary Alveolar Haemorrhage |
3.4% |
| Rash |
3.4% |
| Tachypnoea |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
20.5% |
| Drug Use For Unknown Indication |
14.3% |
| Pain |
8.5% |
| Eye Oedema |
7.8% |
| Analgesic Therapy |
7.6% |
| Anaesthesia |
5.1% |
| Headache |
4.2% |
| General Anaesthesia |
4.0% |
| Blood Cholesterol Increased |
3.3% |
| Hypertension |
2.9% |
| Procedural Pain |
2.9% |
| Crohn's Disease |
2.7% |
| Polyarthritis |
2.7% |
| Sickle Cell Anaemia With Crisis |
2.7% |
| Oedema |
2.2% |
| Completed Suicide |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Neuromuscular Blockade |
1.8% |
| Colon Cancer |
1.6% |
| Pyrexia |
1.6% |
|
| Drug Hypersensitivity |
11.9% |
| Renal Failure Acute |
10.4% |
| Medication Error |
6.0% |
| Pain |
6.0% |
| Post Procedural Haemorrhage |
6.0% |
| Cardiac Arrest |
4.5% |
| Cardio-respiratory Arrest |
4.5% |
| Completed Suicide |
4.5% |
| Drug Ineffective |
4.5% |
| Hyperaesthesia |
4.5% |
| Meningitis Aseptic |
4.5% |
| Pyrexia |
4.5% |
| Respiratory Arrest |
4.5% |
| Urine Porphobilinogen Increased |
4.5% |
| Urticaria |
4.5% |
| Anaemia |
3.0% |
| Conversion Disorder |
3.0% |
| Haemorrhage Intracranial |
3.0% |
| Hyperkalaemia |
3.0% |
| Intentional Overdose |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
18.4% |
| Pain |
14.5% |
| Prophylaxis |
5.9% |
| Hypertension |
5.4% |
| Depression |
5.0% |
| Rheumatoid Arthritis |
3.4% |
| Nausea |
3.1% |
| Abdominal Pain |
2.7% |
| Contraception |
2.7% |
| Constipation |
2.3% |
| Anxiety |
2.2% |
| Asthma |
2.1% |
| Diabetes Mellitus |
1.9% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Headache |
1.8% |
| Arthralgia |
1.7% |
| Migraine |
1.7% |
| Pain Management |
1.7% |
| Premenstrual Syndrome |
1.6% |
|
| Vomiting |
16.2% |
| Pain |
9.0% |
| Pulmonary Embolism |
9.0% |
| Weight Decreased |
7.7% |
| Death |
5.6% |
| Anxiety |
5.1% |
| Myocardial Infarction |
5.1% |
| Weight Increased |
5.1% |
| Pneumonia |
3.8% |
| Dyspnoea |
3.4% |
| Gastroenteritis Viral |
3.4% |
| Renal Failure Acute |
3.4% |
| Unresponsive To Stimuli |
3.4% |
| Visual Impairment |
3.4% |
| Deep Vein Thrombosis |
3.0% |
| Nausea |
3.0% |
| Chest Pain |
2.6% |
| Hypotension |
2.6% |
| Mucosal Inflammation |
2.6% |
| Multi-organ Failure |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
33.3% |
| Glioblastoma |
22.2% |
| Pharyngitis |
22.2% |
| Eye Operation |
16.7% |
| Neuralgia |
5.6% |
|
| Eye Operation |
25.0% |
| Peptic Ulcer Haemorrhage |
25.0% |
| Thrombocytopenia |
25.0% |
| Toxic Epidermal Necrolysis |
25.0% |
|
